rs61755576
Variant summary
Our verdict is Uncertain significance. The variant received -1 ACMG points: 0P and 1B. BP4
This summary comes from the ClinGen Evidence Repository: The c.3235A>G (NM_006939.4(SOS2):c.3235A>G (p.Thr1079Ala)) variant in SOS2 is a missense variant predicted to cause substitution of threonine by alanine at amino acid 1079. The highest MAF in gnomAD v2.1.1 is 0.01703 % in the European (non-Finnish) population (no population codes met). The computational predictor REVEL gives a score of 0.257, which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA7176854/MONDO:0021060/042
Frequency
Consequence
NM_006939.4 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SOS2 | ENST00000216373.10 | c.3235A>G | p.Thr1079Ala | missense_variant | Exon 20 of 23 | 1 | NM_006939.4 | ENSP00000216373.5 | ||
| SOS2 | ENST00000543680.5 | c.3136A>G | p.Thr1046Ala | missense_variant | Exon 19 of 22 | 1 | ENSP00000445328.1 | |||
| ENSG00000308262 | ENST00000832887.1 | n.-103A>G | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152220Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000676 AC: 17AN: 251462 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.000105 AC: 153AN: 1461802Hom.: 0 Cov.: 32 AF XY: 0.000102 AC XY: 74AN XY: 727204 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74364 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.T1079A variant (also known as c.3235A>G), located in coding exon 20 of the SOS2 gene, results from an A to G substitution at nucleotide position 3235. The threonine at codon 1079 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
RASopathy Uncertain:1
The c.3235A>G (NM_006939.4(SOS2):c.3235A>G (p.Thr1079Ala)) variant in SOS2 is a missense variant predicted to cause substitution of threonine by alanine at amino acid 1079. The highest MAF in gnomAD v2.1.1 is 0.01703 % in the European (non-Finnish) population (no population codes met). The computational predictor REVEL gives a score of 0.257, which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). -
not specified Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Noonan syndrome 9 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at